After a sluggish 2023, 2024 looks brighter for healthcare stocks.) might regain their appeal for 2024 and beyond after a lackluster performance in 2023, partly due to their significant outperformance during the COVID-19 pandemic.
Moreover, these stocks are considered defensive, meaning they tend to remain stable during market downturns. This stability is logical because healthcare needs persist regardless of economic conditions; people require medical services, pharmaceuticals, insurance, and medical devices regardless of market performance.
Note that InvestingPro subscribers can reproduce this research on their member area, by applying the following filters on the advanced screener :Among these stocks, those with the greatest upside potential are CVS Health, Incyte Corporation and Viatris, which we'll review using the InvestingPro platform in the remainder of this article.CVS Health Corporation provides healthcare solutions in the United States.
Investors interested in integrating the healthcare sector into their portfolios should therefore further investigate the opportunity to buy these 3 stocks to take a diversified position.10%, thanks to the promo code"ACTUPRO", valid for 1 and 2-year Pro+ and Pro subscriptions!
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: DailyFX - 🏆 305. / 63 Read more »
Source: NBCDFW - 🏆 288. / 63 Read more »
Source: CNBC - 🏆 12. / 72 Read more »